Thinking about COVID-19 almost gives me a migraine, or at least a heavy and achy sensation in my noggin – perhaps not an actual migraine, thankfully, but threatening and unpleasant all the same. Happily, thinking about migraines will not give me COVID-19. But migraines are by no means a topic of no consequence, […]
Articles
When we’re trying to fight against an adversary that is as strong and full of tricks as cancer, what we need to do is look for points of vulnerability – Achilles heels. We all remember, of course, that the mother of Achilles dipped him in the River Styx when he was a tiny boy, […]
Way back in April 2018, the World Health Organization issued its Thirteenth General Programme of Work, which attracted a certain amount of notice at the time, but was certainly not treated as front-page news. The GPW 13, as WHO called it, was centered on three ambitious targets – worthy, but in the view of […]
Putting the name of this imperious disease in the title of my homily places a weighty responsibility on me. Who am I to attempt to put forth relevant information and sensible opinions on this topic, the mere mention of which makes most normal folk distinctly uneasy? But I probably pay more attention to […]
For those of us who live in this part of the country and spend any time messing around outdoors in the grass and weeds, this is the time to be careful about Lyme disease. I had a bout of Lyme 16 years ago, and it descended on me when we were on vacation, driving through […]
When I last took a look at what was happening in the treatment of migraines, I took careful pains to elucidate the differences between migraines and a plain old bad headache – the fact that migraines affect only one side of the head, and a detailed disquisition on the symptoms that many migraineurs (that’s the […]
Glenn Newberry in an earlier post today was asking whether Benlysta from GlaxoSmithKline (GSK), being trialled for lupus nephritis, poses any threat to Aurinia (AUPH). Benlysta is a monoclonal antibody that binds to and inhibits BAFF (B-cell activating factor). A company called Anthera (ANTH) is trialling blisibimod, an oral agent that does the same thing. […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. You can see all of his old articles and his most recent comments on his Stock Gumshoe page.] “Keep it quiet. (Go slow.) […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics and his words and opinions are his own. You can see all of his past articles and most recent comments at his Stock Gumshoe page.] In June 2016, we advanced ScyNexis […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, choses his own topics, and his words and opinions are his own. You can see his past columns and most recent comments on his Stock Gumshoe page.] We first presented Gilead ($GILD) as a long idea […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, he chooses his own topics, and his words and opinions are his own. You can see his biography, previous columns and most recent comments on his Stock Gumshoe page.] “We ran the race, the race […]
Everybody’s got to deviate from the norm. —Rush John Galsworthy wrote that the beginning and endings of human undertakings are untidy. It was never more so than in the early days of HCV, a mere 20 years ago, when a plague first called “non-A non-B hepatitis” began vexing people, progressively scarring their livers and behaving […]
[Ed. Note: Dr. KSS is an MD and PhD who writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see his past articles and recent comments here.] You’re probably getting it right by now—writing “2016” and not “2015.” […]
Alzheimer’s Wrap-Up[ed note: Michael Jorrin, who I like call “Doc Gumshoe,” is a longtime medical writer who shares his thoughts with us a couple times a month — his articles are non-financial in nature, his words and opinions are his own, and you can see his bio and his past pieces here. Enjoy!] Indulge me while […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He choses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Enjoy!] In his smoky baritone, singer Stuart Staples of British midlands musical act Tindersticks is bemoaning how he suspects the woman he […]
[Ed Note: Michael Jorrin, who I like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who shares his thoughts with us from time to time, generally on non-financial topics in health and medicine (as today, though, he sometimes mentions a couple publicly traded companies). His words and opinions are his own. […]
“I firmly believe that if the whole materia medica could be sunk to the bottom of the sea, it would be all the better for mankind and all the worse for the fishes.” — Oliver Wendell Holmes, M. D., Professor of Medicine , Harvard “With all his conscience and one eye askew, So false he […]
[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. His previous columns can be found here. Enjoy!] Every New Year, a friend and I flew to Boston. She’d gone to medical school […]
[Ed. Note: Dr. KSS writes about medicine and biotech for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] Conclusion of a Series on Pain [This column is dedicated to recovery from a recent cancer diagnosis of a stuff-of-legend friend whose life I cherish. She recently […]
[ed. note: Michael Jorrin, who we like to call “Doc Gumshoe”, is a longtime medical writer who shares his thoughts with us a couple times a month. He is not a doctor, and his articles are not typically focused on investment ideas] This post will neither spook you nor cheer you up. In adding Doc […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He chooses his own topics, and his words and opinions are his own.] Careful analysis of Ebola sequences in infected Africans confirms this: the entire present Ebola outbreak emerged as a consequence of one boy in Meliandoua, in eastern Guinea, eating a […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own. Enjoy!] In the Saturday morning Looney Tunes many of us saw as children, one trope always stuck with me: that of the grand piano falling from way up high and crashing, splintering itself. There’s a […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]
[Ed. Note: Dr. KSS, formerly knowns as karmaswimswami on our discussion threads, is here again to talk to the Irregulars about health and medicine and biotech investing ideas. As with all of our guest contributors, he has agreed to our trading restrictions and we have not reviewed, approved or screened his stocks or ideas, and […]
Today we’re sharing another piece from our medical contributor, “Doc Gumshoe” — we have added the stock tickers to the companies he mentions for your researching convenience, but this survey of the state of cancer research — which will hopefully be good background help to folks trying to understand the basic science behind pitches for […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
i has spend time back testing JB's webinar for the timed stock. non of the stocks he mentioned in the talk was verifia...
I looked at the chart that is shown during his presentation when he references the July 30th target, and it matches Homo...
Notice that Jeff Brown is now trading under Brownstone Research not Bonner and Partners .....
Latest News by Jeff Brown, “FDA Fast Tracks $6.8 Billion Miracle Antibiotic for July Approval One microcap owns the ...
Hi, regarding another 9:30AM today... “ What I witnessed in Cambridge” “I saw something I wasn’t supposed to ...
Jeff Brown is claiming a #1 timed stock this week. Anyone know which biotech it is? I know in another discussion from Ja...
Any idea what Jeff Brown’s 3 picks for small IPO’s might be?...
Travis- what’s Jeff Browns ipo 2020 speech about ? This “penny stock” is gonna blow up to $48 .... what do you thi...
Thanks Travis. I do know that such a pitch is a trap to buy an investment letter but thanks to Stock Gumshoe we can get...
Those deadlines are often heavily exaggerated, and sometimes just completely made up -- they're more about getting you t...
Yes, it is SPRO , which stock has shot up the past 2 days....
For the 5G boom, Jeff outlines these - AKTS, LITE, IIVI, MTSI For AI, he outlines - AMBA, YEXT...
I just joined Jeff Brown's service, shelled out $2k and purchased several of his recommended stocks - EDIT, CRSP, NTLA, ...
I am looking at this thread after hearing Jeff Brown's webinar promoting his expensive newsletter for $2000. Today, is A...
I assume you mean Jeff Brown, no? Not Jeff Bezos (of Amazon)? Brown has indeed been touting Editas for a long time...
That’s right! That’s what I have too but where do you get that? Is it a Federal government report or is it a stock m...
He has touted a great many 5G stocks over the past year, including NOK and SWKS and some of the little filter companies ...
Yes, Michael Robinson and Jeff Brown have both heavily teased NOK (and some other names) for their lower-cost newsletter...
Hey Travis, I really enjoy GUMSHOE I can get all the information from here. I bought some (CRON) but after I saw it wasn...
Jeff brown is pushing the Amazon coin and also the two blockchain sockets again right now dec 18....
STAY AWAY FROM Jeff Brown AND BONNER AND PARTNERS. THEY ARE CROOKS. I have purchased shares of EVERY one of the Companie...
The $6 stock that Jeff Brown is saying will form the infrastructure to create trillions isn't QCOM but is more likely NO...
November 7 - I just watched a webinar with the humorless Jeff Brown of Bonner. I feel so foolish as they promise Jeff w...
I watch Jeff Brown the other night 3 times give the same speech. all the time he is saying and I am going to give that s...
What about the $6 Digital King touted by "The Near Future Report" editor, Jeff Brown. He is claiming the new technology...
Wanda did you buy the $74 jeff brown report? What about his stock tips any good? ?is this a scam or worth the money...
Have any of you researched the potential cost of one of these treatments. I'd guess in the hundreds of thousands per pa...
Has the "shoe" figured out what $0.13 Tech Stock-is a no brainer from Jeff Brown this week?...
I watched Jeff Brown's pitch on crypto currency in the rest of his topics. I really believe he is full of crap because I...
Jeff Brown from Bonner & Partners is also selling information on biotech companies who are about to release trial re...
JEFF BROWN IS VERY CONFUSING TO FOLLOW HE IS AGAINST WHAT HE IS FOR....AND VICE VERSA.......
Have you had any requests to find out what Jeff Brown is touting for Bonner. He says he has two companies tied to crypto...
I would like to to see Jeff Brown and others pitch a new tech company, not regurgitate old ones. They're all the same. ...
I think this is about the Jeff Brown tease -- we covered that here: https://www.stockgumshoe.com/reviews/near-future-rep...
Mining rigs and blockchain node servers don’t use a ton of DRAM, but they must use solid state drives, made from NAND ...
I wrote about a different Jeff Brown pitch recently, but haven't seen him hint at any blockchain investments of late -- ...
Ok I'll admit it...I love to gamble. Jeff brown sounded like a snake oil dealer and i'm probably not wrong. I'm not real...
I realize this thread is well over a year old, but it looked like the best place to plug in to the topic of driverless c...
A bill Bonner Jeff Brown? investment letter...
Gene hacking stock commented by Jeff Brown is Editas medicine...